Advertisement

Topics

Eye disease - Biotech, Pharma and Life Science Channel

17:22 EDT 24th May 2017 | BioPortfolio

PubMed Articles [16232 Associated PubMed Articles listed on BioPortfolio]

The effect and safety of monoclonal antibodies to calcitonin gene-related peptide and its receptor on migraine: a systematic review and meta-analysis.

Migraine has been recognized as one of the leading causes of disability in the 2013 Global Burden of Disease Study and seriously affects the quality of patients' life, current treatment options are no...

Extracorporeal CO2 removal by hemodialysis: in vitro model and feasibility.

Critically ill patients with acute respiratory distress syndrome and acute exacerbations of chronic obstructive pulmonary disease often develop hypercapnia and require mechanical ventilation. Extracor...

Anal metastasis of rectal cancer-adenocarcinoma of squamous cells: a case report and literature review.

Anal metastasis of colorectal cancer is very rare and is usually associated with a history of anal disease, including anal fistula, fissure, hemorrhoidectomy, and anastomotic injury. We report a case ...

A case of sarcoidosis with isolated hepatosplenic onset and development of inflammatory bowel disease during recovery stage.

Sarcoidosis is a systemic disease characterized by an immune-mediated disorder, which leads to the development of non-caseating granulomas in the involved organs. More than 90% of patients with sarcoi...

Global Hopf bifurcation analysis of an susceptible-infective-removed epidemic model incorporating media coverage with time delay.

An susceptible-infective-removed epidemic model incorporating media coverage with time delay is proposed. The stability of the disease-free equilibrium and endemic equilibrium is studied. And then, th...

Development of a SYBR Green I real-time PCR for the detection of the orf virus.

Orf is a non-systemic, ubiquitous disease of sheep and goats caused by the orf virus (ORFV). ORFV occasionally causes cutaneous lesions in humans in contact with infected animals. In the present study...

Undifferentiated carcinoma of the ampulla of Vater.

Undifferentiated carcinoma of the ampulla of Vater is a rare disease with unclear and clinical characteristics and prognosis. Here, we report the case of a 61-year-old man with undifferentiated carcin...

Transanal total mesorectal excision for a large leiomyosarcoma at the lower rectum: a case report and literature review.

Rectal leiomyosarcoma (LMS) is an extremely rare disease. Previously, LMS was not properly distinguishable from gastrointestinal stromal tumor (GIST) until c-kit, a characteristic marker of GIST, was ...

Blood perfusion in osteomyelitis studied with (15)Owater PET in a juvenile porcine model.

Osteomyelitis is a serious disease which can be difficult to treat despite properly instituted antibiotic therapy. This appears to be related at least partly to degraded vascularisation in the osteomy...

Distinguishing features of acute Vogt-Koyanagi-Harada disease and acute central serous chorioretinopathy on optical coherence tomography angiography and en face optical coherence tomography imaging.

The aim of this study is to determine the differences in optical coherence tomography angiography (OCTA) features of acute Vogt-Koyanagi-Harada disease (VKH) and acute central serous chorioretinopathy...

News Articles [10039 Associated News Articles listed on BioPortfolio]

Japan Infectious Diseases: Sales and Volume Segment Forecasts for 100 Tests, Supplier Shares by Test, Innovative Technologies, Competitive Strategies, Emerging Opportunities [Updated: 30092016] Prices from USD $8800

Complete report $8,800. nbsp;DataPack test volumes, sales forecasts, supplier shares $5,700.VPG Market Research's new report is a strategic analysis of major business opportunities emerging in the inf...

2016 Netherlands Infectious Disease Testing Market: Volume and Sales Forecasts for 100 Tests, Competitive Strategies, Innovative Technologies, Opportunities for Suppliers [Updated: 16102016] Prices from USD $4500

This new report from VPG Market Research is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the infectious disease testing mar...

20162020 Canada Infectious Disease Testing Market: Volume and Sales Forecasts for 100 Tests, Competitive Strategies, Innovative Technologies, Opportunities for Suppliers [Updated: 06052016] Prices from USD $4500

This new report from VPG Market Research is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the infectious disease testing mar...

2017 Emerging Infectious Disease Testing Technologies and Strategic Profiles of Leading Suppliers [Updated: 18012017] Prices from USD $3850

This 155page report provides detailed analyses of current and emerging technologies, and their potential applications for the infectious disease testing market, including molecular diagnostics, biochi...

U.S. FDA panel backs Puma Biotech's breast cancer drug

WASHINGTON (Reuters) - Puma Biotechnology Inc's experimental breast cancer drug reduces the risk of disease recurrence and should be approved, an advisory committee to the U.S. Food and Drug Administr...

For healthier arteries, eat more fruits and vegetables

(Reuters Health) - Eating more fruits and vegetables may reduce the risk of peripheral artery disease, according to a study of more than 3.6 million individuals in the U.S.

Italy Diagnostics Market: Instrument and Reagent Supplier Shares by Test, Business Environment, Market Structure [Updated: 01072016] Prices from USD $4850

This new report from VPG Market Research provides an overview of the Italian diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test v...

Cerveau Technologies, Inc. Collaborates With Singapore’s Clinical Imaging Research Centre

Cerveau Technologies, Inc. today announced a research collaboration with the Clinical Imaging Research Centre (CIRC), a joint venture by the Agency for Science, Technology and Res...

FDA panel backs Puma Biotech's breast cancer drug

(Reuters) - Puma Biotechnology's experimental breast cancer drug reduces the risk of the disease returning and should be approved, an advisory committee to the U.S. Food and Drug Administration conclu...

Genetic mutation studies help validate new strategy for reducing lipids, cholesterol

A new strategy - an injectable antibody - for lowering blood lipids and thereby potentially preventing coronary artery disease and other conditions caused by the build-up of fats, cholesterol, and oth...

Events [0 Results]

None

Companies [336 Associated Companies listed on BioPortfolio]

Rare Disease Communications

Rare Disease Communications® is a healthcare communications and media company focused on the rare disease community and dedicated to raising awareness of rare diseases and orph...

Pulmonx, Inc.

Based in Redwood City, California, and Neuchâtel, Switzerland, Pulmonx is an interventional pulmonology company focused on developing life-changing, cost-effective technologies...

HealthReveal

HealthReveal is a healthcare technology company whose mission is to preempt the avoidable consequences of chronic disease. A fundamental component of fulfilling this mission is en...

Tmunity Therapeutics, Inc.

Tmunity Therapeutics is a private biotherapeutics company focused on saving and improving lives by delivering the full potential of next-generation T cell immunotherapy to patient...

Opsis Therapeutics

Opsis Therapeutics is a company focused on discovering and developing new medicines to restore vision to patients suffering from retinal diseases. By combining recent innovations ...

EverlyWell

Founded in 2015, EverlyWell offers a suite of regulatory-compliant, physician-reviewed, at-home lab tests, without a lab visit or an in-person doctor referral. The platform empowe...

Susan G. Komen and Manduka

Susan G. Komen is the world’s largest breast cancer organization, funding more breast cancer research than any other nonprofit outside of the federal government while providi...

LimFlow SA

LimFlow is a private, venture-backed medical device company transforming the treatment of Critical Limb Ischemia, a growing clinical need in the face of the prevalence of diabetes...

Tiziana Life Sciences plc

Tiziana Life Sciences plc is a UK biotechnology company that focuses on the discovery and development of novel molecules that treat human disease in oncology and immunology. The C...

Mobidiag

Founded in the year 2000, Mobidiag is specialized in the molecular diagnostics of infectious diseases. The focus area of the company is primarily to develop high-quality content for DNA biochip-based ...

Clinical Trials [2074 Associated Clinical Trials listed on BioPortfolio]

The QUALITY Vets Project: Muscle Quality and Kidney Disease

Currently there is no standard way to detect age-related skeletal muscle loss in patients with chronic kidney disease. Investigators are working on finding rapid and inexpensive ways to me...

Role of IL-37 Genetic Variants in Modulating Innate Immune Response to Periodontal Pathogens

This study will provide mechanistic insight into the underlying causes and molecular level pathogenesis of periodontal diseases. We will identify key mechanisms that confer risk and protec...

A New Model of Acute Febrile Disease

We want to establish a new model of acute febrile disease by mimicking the conditions seen in hospitalized patients in regards to inflammation, immobilisation and fasting. In this new mode...

Clinical Trial of Efficacy and Safety of Rengalin in the Treatment of Cough in Patients With Chronic Obstructive Pulmonary Disease

The purpose of this study is to obtain additional data on efficacy and safety of Rengalin in the treatment of cough in patients with stable obstructive pulmonary disease

An Open-Label Phase II Study to Evaluate the Efficacy and Safety of IdeS in Anti-GBM Disease (GOOD-IDES)

This study will evaluate the safety and tolerability of IdeS in patients with severe anti-GBM (Glomerular Basement Membrane) disease receiving standard care consisting of pulse-methylpredn...

Prevalence of Hypertensive Disease in Patients Presenting for Elective Surgery in the Western Cape, South Africa

Hypertension is a major medical and public health burden throughout the world. It is estimated that 1 in 3 adult South Africans are diagnosed with hypertension, however detailed statistics...

Early-onset Alzheimer's Disease Phenotypes: Neuropsychology and Neural Networks

This study attempts to identify two types of AD by using clinical and cognitive tasks and brain imaging. The subtypes of AD are separated into a "typical" group (memory loss) and a "varian...

The Prospective Cohort Study on the Benefit-risk of Antithrombotic or Anticoagulant Therapy in Patients With Unruptured Intracranial Aneurysms Associated With Ischemic Heart Disease or Ischemic Cerebrovascular Disease

This is a registry study of the natural course of unruptured intracranial aneurysms (UIA). In addition, the investigators will analyze the benefit-risk of antithrombotic or anticoagulant t...

Cardiopulmonary Exercise Test to Quantify Enzyme Replacement Response in Pediatric Pompe Disease

Introduction: Enzyme replacement therapy (ERT) with Myozyme improved the prospect of Pompe disease patients. Our aim was to evaluate ERT acute effect on exercise capacity in pediatric Pomp...

The Correlation Between Anemia of Chronic Diseases, Hepcidin and Vitamin D in IBD Patients

Crohn's disease (CD) and ulcerative colitis (UC) are chronic gastrointestinal diseases characterized by relapsing and remitting inflammation of the intestines Anemia may often complicate t...

Videos

None available.

Medical and Biotech [MESH] Definitions

Animate or inanimate sources which normally harbor disease-causing organisms and thus serve as potential sources of disease outbreaks. Reservoirs are distinguished from vectors (DISEASE VECTORS) and carriers, which are agents of disease transmission rather than continuing sources of potential disease outbreaks.

Analyses for a specific enzyme activity, or of the level of a specific enzyme that is used to assess health and disease risk, for early detection of disease or disease prediction, diagnosis, and change in disease status.

The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.

Quick Search
Advertisement
 
review and buy Eye disease market research data and corporate reports here

Channels Quicklinks